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The members of the atypical Protein Kinase Cs (aPKC) kinase subfamily, PKCζ and PKCλ/ι,
as well as their adapters, p62 and Par-6, form part of the PB1-domain-containing group
of signaling regulators. Both adapters serve to locate through heterotypic interactions the
aPKCs into the NF-κB and cell polarity pathways, respectively. Both signaling cascades have
been critically implicated inT cell function in vitro and in vivo.The analysis of gene-knockout
(KO) mice deficient in the different PB1 molecules is providing more definitive information
on the actual role that the aPKCs and other PB1-containing molecules play in B cell biology
andT cell polarity, survival, and differentiation toward the different effector lineages in vivo
and at the cellular ex vivo level. Here we discuss recent data generated from the analysis
of KO mice linking the control of cell polarity by PKCλ/ι and PKCζ, their adapter p62, and
the Par-4 inhibitor, in the control of B and T cell signaling and differentiation. Altogether,
these genetic and biochemical evidences reveal the existence of a PB1-orchestrated sig-
naling network that acts to control Th2 differentiation in vitro and in vivo, and the gene
transcriptional programs that are essential during the B cell maturation and function and
Th2 differentiation.
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INTRODUCTION
It is well known that cells from the adaptive immune system
need proper activation of the nuclear factor κB (NF-κB) for their
function and development. NF-κB provides necessary mediators
for the survival of immature T and B cells in antigen receptor-
mediated negative and positive selection of non-reactive clones
in thymus and bone marrow, respectively. NF-κB activation is
also necessary for mature lymphocyte differentiation and func-
tion (Hayden et al., 2006; Schulze-Luehrmann and Ghosh, 2006).
However, uncontrolled activation of NF-κB can induce cancer
development, autoimmune, and chronic inflammatory diseases
as a result of exacerbated lymphocyte function (Karin and Greten,
2005). The Protein Kinase Cs (PKCs) family is an important piece
in the puzzle of NF-κB-mediated cell activation and several stud-
ies on recent years have demonstrated that proteins of this family
are potent mediators of antigen receptor downstream signaling in
B and T cells. Hence, these proteins are key in both, the develop-
ment and the control of innate and adaptive immune responses.
Since there are three different families of PKCs; classical PKCs
(PKCα, βI, βII, γ), novel PKCs (PKCδ, ε, η, θ), and atypical PKCs
(aPKCs; PKCζ, λ/ι), some of the lymphocyte signaling pathways
controlled by these kinases can be redundant although they have
distinct in vivo functions due to their broad substrate specificity.
For example, in addition to NF-κB they are also involved in AP-1
or NFAT transcription factors activation in T cells (Tan and Parker,
2003). In this review we discuss the mechanisms by which aPKCs
regulate T and B cell signaling after antigen stimulation and the
role of the aPKCs-associated molecules Par-4, a potent inhibitor of
aPKCs, and the scaffolding protein p62 in lymphocyte activation
and differentiation.
ATYPICAL PKCs IN B CELL BIOLOGY
B cells are lymphocytes originated from lymphoid precursors in
the bone marrow after rearrangement of the immunoglobulin
genes to provide the immune system with the specific repertoire
of B cells to protect the body against pathogens (Harwood and
Batista, 2010). B cells generation from hematopoietic precursors
needs four different steps to take place: early pro-B cells, late
pro-B cells, pre-B cells, and immature B cells formation. Before
immunoglobulin gene rearrangement starts, the early pro-B cell
subset emerges from the precursors giving rise to the following
subset of late pro-B cells. In this step begins the rearrange-
ment of D and J gene segments to generate pre-B cells with
intact immunoglobulin heavy chains. When the rearrangement
of the light-chain genes is completed the immature B cell subset
is formed, expressing IgM on cell surface (B220low MHC-IIhigh
IgMhigh IgDlow). At this step, B cells undergo a selection process
to eliminate self-reactive cells to avoid autoimmunity before going
out to periphery. Once positioned in secondary lymphoid organs,
immature B cells become transitional B cells that are ready to
maturate within the follicles in lymph nodes or in the marginal
zone of the spleen (marginal zone B cells). After antigen challenge,
mature B cells (B220high MHC-IIhigh IgMlow IgDhigh) become
antibody-secreting plasma cells in germinal centers or memory
B cells distributed elsewhere (Hardy and Hayakawa, 2001). The
role of PKCs in these processes as well as in the activation and
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function of mature B cells is from diverse nature. Is important
to remark that, unlike what is described for other PKCs, PKCδ is
involved in the generation of B cell tolerance and anergy (Meck-
lenbrauker et al., 2002; Miyamoto et al., 2002) whereas PKCβ and
PKCζ have a different role in B cell biology. Mice deficient for
PKCβ has defective B cell signaling (Leitges et al., 1996) and PKCζ
deficiency is associated to defects in B cell development, prolifera-
tion, and survival (Leitges et al., 2001; Martin et al., 2002; Moscat
et al., 2003).
Role of PKCζ in secondary lymphoid organ maturation and B cell
differentiation
Although the lack of PKCζ in mice generates no apparent abnor-
mality, the formation, and maturation of secondary lymphoid
organs is altered during the first weeks after birth. In this regard, 2–
4 weeks old mice fail to develop an appropriate number of Peyer’s
patches (PP) with an important reduction in follicles size and
total cell number within each PP. Moreover, internal structure of
PPs is also impaired as B and T cell zones are disrupted, this is
due in part to the almost total lack of follicular dendritic cells
(FDCs) that organized follicles structure. B cell zones are reduced
and there is an imbalance between B220high MHC-IIhigh IgMlow
IgDhigh mature and B220low MHC-IIhigh IgMhigh IgDlow imma-
ture B cells that is also observed in adult mice (Leitges et al., 2001).
Regarding the spleen of these mice, although grossly normal, they
present a defect in the formation of B cell follicles in the white
pulp. The deficiency of FDCs in this organ induces disruption of
the marginal zone architecture. Accordingly there is a decrease in
the percentage of mature BCs in lymph nodes. However most of
these defects are overcome in adult animals indicating that PKCζ
could have an important role in B cell maturation in young ani-
mals that can be compensated by other molecules in adult mice
(Leitges et al., 2001). In this regard it is important to note that B
cell subpopulations in spleens and lymph nodes are normal and
also microarchitecture of these organs has no apparent defects in
adult animals.
B cell activation and survival is dependent of PKCζ signaling
In depth study of the role of PKCζ in B cell signaling indicates that
this aPKC is required for an optimal survival rate, cell cycle entry,
and proliferation after B cell receptor (BCR) stimulation in adult
animals (Martin et al., 2002). As stated before, B cell subpopulation
and lymphoid organ architecture of 4–6 weeks old animals is quite
normal. In contrast to that observed in embryonic fibroblasts (EFs;
Leitges et al., 2001), studies with PKCζ-deficient mice indicate that
the defects in B cell activation and proliferation correspond to
impaired activation of extracellular signal-regulated kinase (ERK),
whereas the activation of other mitogen-activated protein kinases
(MAPK) is not altered. Regarding transcription factors activation
through PKCζ, a small decrease in activating protein-1 (AP-1)
transcription factor activation is observed along with an inhibi-
tion of c-Fos induction in PKCζ-deficient mice (Martin et al., 2002;
Figure 1A). Although PKCζ is an important mediator of the NF-κB
pathway (Leitges et al., 2001), the activation and nuclear translo-
cation of this transcription factor is not inhibited in BCs from
PKCζ-deficient mice. However, activation of IkB transcription is
severely impaired in PKCζ-deficient B cells after BCR stimulation
and more importantly, transcription of NF-κB-dependent genes
such as IL-6 or Bcl-XL (important for B cell survival) is also inhib-
ited (Figure 1A). These data demonstrate that although PKCζ is
important for the transcription of NF-κB-dependent genes associ-
ated with proliferation and survival, and consistent with previous
data of EF from PKCζ-deficient mice (Leitges et al., 2001), NF-κB
nuclear translocation is not affected in the absence of this molecule
in B cells (Martin et al., 2002).
Adaptive immune responses are altered in PKCζ-deficient mice
PKCζ is an essential kinase for B cell survival and function
through the activation of IkB and Bcl-XL transcription (Martin
et al., 2002). These data agree with the notion that Rel, RelA,
and NF-κB1 transcription factors are essential in B cell devel-
opment, survival, proliferation, and immunoglobulin expression
(Grossmann et al., 2000; Gugasyan et al., 2000). The lack of
Rel/NF-κB genes or the individual subunits of the IκB kinase,
IKKα and IKKβ, alters the development of adaptive immune
response (Gerondakis et al., 1999). Accordingly, although PKCζ-
deficient mice develop immune responses against T-independent
and -dependent antigens and are able to induce the formation of
germinal centers in the spleen, the T-dependent humoral immune
responses are very faint. The secretion of IgG1, IgG2a, and IgG2b
immunoglobulins, specific for dinitrophenyl-ovalbumin (DNP-
OVA) T-dependent antigen, is almost abrogated in PKCζ-deficient
mice, indicating that these mice are not able to mount a proper
humoral response against T-dependent antigens (Martin et al.,
2002; Figure 1A).
Even nowadays there is little information on the role of the
other family member of aPKCs, the PKCλ/ι, in secondary lym-
phoid organ development or signaling downstream BCR in mature
B cells. This is in part due to the lack of viable homozygous defi-
cient mice for PKCλ/ι as these mice die before birth (Soloff et al.,
2004; Yang et al., 2009), which is incompatible with the study
of mature B cells. While more effort needs to be done to clarify
this issue, PKCλ/ι seems not to be activated after BCR stimula-
tion or after incubation with anti-CD40 indicating that this aPKC
could not be playing any role in B cell biology (Martin et al.,
2002). In summary, PKCζ plays a major role in lymphoid organ
formation and B cell differentiation and function that could be
non-redundant with the other aPKCs, the PKCλ/ι.
Role of PKCλ in B cell development
The role of PKCλ/ι in BC development or function has not been
studied in such detail so as PKCζ. However it is known that PKCλ is
involved in pre-BCR-induced activation of NF-κB in B cells under-
going maturation process (Saijo et al., 2003). Src-family protein
tyrosine kinases (SFKs) have an important role in the first steps
during B cell development, controlling the generation, and sur-
vival of pre-B cells (Wechsler and Monroe, 1995). These effects
are mediated by NF-κB thus in the absence of SFKs, IKK phos-
phorylation is inhibited and the nuclear translocation of NF-κB
is impaired inducing defects in the formation of pre-B cells. It
has been proposed that the atypical PKCλ is a mediator of SFK
induced activation of NF-κB in immature B cells, since PKCλ acti-
vation in pro-B cells deficient for SFK restores IKK activation and
NF-κB-mediated signaling (Saijo et al., 2003). The mechanisms of
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FIGURE 1 | Atypical PKC signaling pathways leading to lymphocyte
activation and/or differentiation. (A) Signaling through B cell antigen
receptor (BCR) in B-lymphocytes. PKCζ is required for the activation of
ERK after antigen challenge and necessary for IκB transcription and for
the activation and nuclear translocation of c-Fos. The transcription of
NF-κB-dependent genes IL-6 and Bcl-XL, and the secretion of T-dependent
immunoglobulins depend on PKCζ-mediated signaling. The aPKC
inhibitor Par-4 blocks PKCζ activation and B cell proliferation. (B) Signaling
pathways in T lymphocytes. After antigen presentation, downstream
signaling through T cell receptor (TCR) takes place. Atypical PKCζ and
PKCλ/ι are important for IKK activation and NF-κB nuclear translocation,
together with p62 scaffold protein that links the aPKCs with TCR
activation through MALT-1 and TRAF-6 proteins. Moreover PKCλ/ι
activates JNK and NFATc1 nuclear translocation, required for Th2
differentiation of T cells. Signaling through IL-4 receptor (IL-4R) requires
both atypical PKCs to fully activate Jak1/Stat6 pathway and therefore to
Th2 differentiation. Par 4 inhibits TCR and IL-4R signaling pathways
blocking the activation of aPKCs.
IKK activation by PKCλ are not addressed, however it could be
a direct association by the consensus phosphorylation site Ser177
(Lallena et al., 1999), or by an indirect interaction with Bcl10 and
Carma1 (Gaide et al., 2002).
T CELL SIGNALING AND ATYPICAL PKCs
The nature of effector T lymphocytes and their functional prop-
erties into inflammatory tissues has been a matter of study during
decades. However, in the last few years the paradigms of effector
cell populations at the site of inflammation has changed consid-
erably with the emergence of new players. After the infection of
invading pathogens or during inflammation, T cell activation, and
subsequent differentiation of T helper lymphocyte subsets are cru-
cial for the development of immune responses. Once the antigen
presenting cell presents the antigen to naïve CD4 T cells, these cells
experienced differentiation toward Th1, Th2, or Th17 T helper cell
subsets in the lymph nodes. Afterward, T helper cells migrate to
the inflamed tissue and develop an adaptive immune response.
Th1 cells are characterized by the expression of T-bet and the
release of the Th1-related cytokine IFN-γ. Th1 cells are involved
in the generation of autoimmunity and inflammatory disorders
mediated by cellular immune responses such as the clearance of
pathogens. The effector subset Th2 is essential for the develop-
ment of inflammatory conditions mediated by antibodies and in
the generation of allergic responses such as asthma. Th2 cells pro-
duce mainly IL-4, IL-5, and IL-13 among other cytokines and
express the transcription factors GATA-3, Stat6, and c-Maf. And
the more recently discovered T helper subset, the Th17 cells are
characterized by the synthesis of IL-17A, IL-17F, and IL-22. Th17
cell emerged as an independent differentiation pathway as the
express a different panel of transcription factors such as Stat3 and
RORγt (Harrington et al., 2005; Bettelli et al., 2007; Nakayamada
et al., 2012). The role of classical and novel PKCs in T cell recep-
tor (TCR) signaling and T cell differentiation into helper T cells
have been addressed extensively. PKCθ is recruited to the T cell
synapse after TCR stimulation, what makes this PKC essential for
the downstream signaling through NF-κB (Liu et al., 2000). The
function of this PKC in T cell signaling is shared with PKCα, since
both PKCs mediate T lymphocyte activation (Gruber et al., 2009).
However PKCθhave different roles in Th1, Th2, or Th17 differenti-
ation. PKCθ-deficient mice develop normal Th1 responses toward
intracellular pathogens whereas Th2 asthmatic response against
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Helminth infection is impaired. Regarding Th17 responses, PKCθ
is required for the development of IL-17-driven experimental
autoimmune encephalomyelitis (Marsland and Kopf, 2008).
PKCζ and T helper differentiation
In contrast to other PKCs, such as PKCθ, essential for T cell
activation (Sun et al., 2000), PKCζ-deficient T cells show nor-
mal proliferation and survival rates after TCR stimulation with
anti-CD3 and anti-CD28 antibodies (Martin et al., 2002). Further
studies on the differentiation of T helper subsets have revealed
that Th1 differentiation from PKCζ-deficient naïve CD4+ T cells
appear not to be affected in this function, as the release of the typ-
ical Th1-associated cytokine IFN-γ is not affected by the lack of
PKCζ. However PKCζ is definitely necessary for the differentiation
of naïve T cells into Th2 cells (Martin et al., 2005; Figure 1B).
PKCζ-deficient CD4+ T cells differentiated in vitro under Th2
polarizing conditions secrete low levels of Th2-related cytokines
IL-4, IL-5, IL-10, and IL-13, compared to the amount of cytokines
released by CD4+ T cells from WT mice. These defects in Th2
differentiation are due to the almost completely lack of nuclear
translocation and activation of GATA-3, Stat6, RelA, c-Maf, and
NFATc1, all of them essential transcription factor for Th2 polar-
ization (Zhu et al., 2010). The main cytokine produced by Th2
cells is IL-4 and exerts its function through the IL-4 receptor and
the subsequent activation of the downstream Jak1/Stat6 signal-
ing pathway. Importantly, PKCζ interacts with and phosphorylates
Jak1 hence controlling the IL-4/Stat6 signaling pathway in T cells
(Duran et al., 2004a; Figure 1B). As a consequence PKCζ-deficient
mice develop a mild form of concanavalin A-induced hepatitis,
a disease dependent of T cell activation through the IL-4/Stat6
pathway (Jaruga et al., 2003), with a severe decrease in leukocyte
infiltration and liver apoptosis (Duran et al., 2004a). Moreover
PKCζ is an important player in the Jak1/Stat6 signaling cascade
involved in the activation through IL-4 and in Th2 differentia-
tion. In this regard Th2 cells play an important role in humoral
immunity against extracellular pathogens and in allergic reactions.
Consequently, Th2 responses are inhibited in OVA-induced aller-
gic airway inflammation in PKCζ-deficient mice. The adoptive
transfer of PKCζ-expressing Th2 cells from WT mice to PKCζ-
deficient mice induces severe inflammation in the lungs indicating
that PKCζ is a critical molecule in the mechanisms of Th2 induc-
tion of inflammation in the airways after antigen exposure (Martin
et al., 2005).
PKCλ/ι and T helper differentiation
The atypicals PKCζ and PKCλ/ι share a significant structural
homology (Diaz-Meco and Moscat, 2012) however, both PKCs
play a different role in the activation and proliferation of naïve
T cells. In contrast to PKCζ-deficient T lymphocytes, PKCλ/ι-
deficient naïve T cells, isolated from conditional PKCλ/ι knockout
(KO) mouse in which PKCλ/ι is specifically deleted in activated
T cells by crossing PKCλ/ιfl/fl with CreOX40 mice, have impaired
proliferation after TCR stimulation (Martin et al., 2005; Yang et al.,
2009). Moreover, PKCλ/ι-deficient CD4+ T cells secrete low lev-
els of Th2 typical cytokines IL-4 and IL-13 whereas the secretion
of IFN-γ by these cells is completely normal after TCR stimula-
tion with anti-CD3 and anti-CD28 antibodies (Yang et al., 2009).
Interestingly, the addition of IL-4 to PKCλ/ι-deficient T cells cul-
tured under Th2 differentiation conditions restores the ability to
secrete IL-4 and IL-13 cytokines by polarized PKCλ/ι-deficient
Th2 cells. Therefore, while PKCλ/ι is important for the prolifera-
tion and Th2-cytokine secretion by naïve T cells, PKCζ is critical
for Th2 development and function (Martin et al., 2002; Yang et al.,
2009; Figure 1B).
However, other important aspects for the development of
immune responses in vivo are shared by these two aPKCs. The
levels of expression of both proteins are very similar in lung
tissue (Leitges et al., 2001; Martin et al., 2002) and are much
more expressed in Th2 cells than in Th1 or non-skewing Th0
cells (Martin et al., 2002; Yang et al., 2009). Accordingly to PKCζ-
deficient mice, PKCλ/ιfl/fl CreOX40 mice have decreased allergic
airway inflammation in lungs after OVA challenge, although this
inhibition of asthmatic response is more dramatic under PKCλ/ι
deficiency (Yang et al., 2009). Conditional PKCλ/ι-deficient mouse
is unable to recruit eosinophils to the lungs and also have very low
levels of IL-4 and IL-13 Th2-related cytokines in the broncho-
alveolar lavage (BAL) fluid, compared to WT mice. This is con-
sistent with significantly reduced levels of IgE specific for OVA
in the serum of PKCλ/ιfl/fl CreOX40 mice challenged with OVA.
This is another feature shared with PKCζ-deficient mouse, defects
in airway inflammation in this model of allergic asthma are
due to an deregulation in the activation and nuclear transloca-
tion of GATA-3, NFATc1, p65, and Stat6 in T cells (Yang et al.,
2009).
PARTNERS OF aPKCs IN T CELL ACTIVATION AND ADAPTIVE IMMUNE
RESPONSES
The two isoforms of aPKCs, ζ and λ (ι in humans) are highly
homologous at the amino acid level (Selbie et al., 1993; Akimoto
et al., 1994). aPKC amino-terminal domain encodes several pro-
tein interaction sequences including a PB1 domain (Phox and
Bem1p), a protein–protein interaction domain shared by other
adapter proteins such as p62, Par-6, or NBR1 (Moscat and Diaz-
Meco, 2000; Ito et al., 2001), and the C1 domain that interacts
with the protein Par-4, an inhibitor of aPKCs enzymatic activity,
by a zinc-finger domain (Diaz-Meco et al., 1996). Together with
the aPKCs, p62 and Par-4 interacting proteins have an important
role in the control of T cell activation and in the development of
adaptive immune responses.
Par-4, an inhibitor of aPKCs, controls the strength of B and T cell
responses
The aPKC inhibitor Par-4 plays an important role in the mod-
ulation of apoptosis through the regulation of NF-κB activation
(Garcia-Cao et al., 2003). Par-4 inhibitor was first described in
prostate cancer cells and linked to neoplastic alterations in the
prostate (Sells et al., 1994; Barradas et al., 1999) moreover it is
known that this protein plays also an important role in B and
T cell activation and proliferation. Par-4 deficient mice develop
spontaneous splenomegaly, although present normal proportions
of T and B cells in primary and secondary lymphoid organs in
steady state (Lafuente et al., 2003). However, B and T cells isolated
from Par-4 deficient mice have an increased proliferation rate after
antigen receptor stimulation compared to WT mice, indicating
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that this protein acts at the level of antigen receptor signaling.
Interestingly Par-4 deficient T cells secrete high amounts of IL-2
in vitro after stimulation. As Par-4 is a pro-apoptotic protein, Par-4
deficient T cells are more resistant to apoptosis induced cell death
than their WT T cell control (Lafuente et al., 2003). As it was pre-
viously mentioned, aPKCs downstream signaling cascade controls
NF-κB activation (Leitges et al., 2001) and, in turn, Par-4 inhibits
this pathway and proliferation of T cells through the inhibition of
aPKCs phosphorylation. Then, it seems that Par-4-mediated inhi-
bition of T cell proliferation is not controlled through PKCζ since
the proliferation of T cells from PKCζ-deficient mice is normal
(Martin et al., 2002). Hence Par-4 should exert its effect through
the other aPKC, the PKCλ/ι. Moreover, primary EFs from Par-
4-deficient mice have decreased JNK activation that is observed
also in T cells from these mice (Garcia-Cao et al., 2003; Lafuente
et al., 2003). JNK is a potent inhibitor of NFATc1 transcrip-
tion factor essential for T cell differentiation and function and
accordingly Par-4 deficient T cells have an increase in NFATc1
activation, which may explain the high levels of IL-2 secretion by
these cells that could directly influence the high rate of prolifer-
ation of Par-4-deficient T cells (Chow et al., 2000; Crabtree and
Olson, 2002). A well as PKCζ and PKCλ/ι play an important role
in T cell differentiation toward helper subsets, Par-4 is impor-
tant for the control of Th2 responses. Par-4 deficiency leads to
aPKC hyperactivation and subsequent inhibition of JNK, signal-
ing pathway required for the control of IL-4 secretion, and Th2
differentiation (Dong et al., 1998; Figure 1B). Moreover, in vivo
experiments in a model of T cell-dependent hepatitis have demon-
strated that Par-4 deficiency leads to an increase in IL-4 signaling
pathway, increasing the levels of Th2-cytokines, eotaxin, apopto-
sis, and liver injury after treatment with Con-A. These results are
consistent with an enhanced signaling downstream IL-4 in EFs
from Par-4 deficient mice, where Jak1 and Stat6 phosphorylation
is increased demonstrating a connection with an enhanced signal-
ing through aPKC (Duran et al., 2004a; Martin et al., 2005; Yang
et al., 2009).
aPKC scaffold protein p62 controls T helper differentiation
The adapter protein p62 interacts with aPKCs through their PB1
protein interaction domain and is essential in the maintenance
of NF-κB activity during osteoclastogenesis (Duran et al., 2004b).
Similarly is a key protein for the long-term NF-κB activation after
TCR stimulation of naïve CD4+ T cells (Martin et al., 2006).
Unlike PKCζ and PKCλ/ι do, p62 controls Th2 differentiation
and function by an IL-4 independent mechanism. Th2 cells defi-
cient for p62 have impaired activation and nuclear translocation
of GATA-3 and RelA, playing an important role in NF-κB activa-
tion, whereas Stat6 signaling through IL-4 receptor is not affected
(Das et al., 2001; Martin et al., 2006). In this regard, proximal TCR
downstream signaling pathway is not altered in the absence of
p62 as Zap-70, ERK, or AKT activation and Ca2+ flux are normal
after antigen receptor triggering. Degradation of IκBα, an early
indicator of NF-κB activation, is also intact in p62-deficient cells
while IκBα activation is inhibited several hours after TCR trig-
gering along with NF-κB inhibition. Interestingly, p62 expression
is induced at later time points after TCR stimulation and particu-
larly under Th2 differentiation conditions. This is possible because
p62 establish a connection with Malt-1 and TRAF6, both proteins
involved in IKK ubiquitination (Wooten et al., 2005), favoring NF-
κB activation after long-term TCR stimulation probably through
PKCλ/ι (Figure 1B). Accordingly with impaired Th2 differentia-
tion in vitro, p62-deficient mice also show a dramatically reduction
of lung inflammation toward OVA-induced allergic airway disease
demonstrating a key role of p62 in Th2 function in vivo (Martin
et al., 2006).
CONCLUDING REMARKS
It is clear that over the recent years the aPKCs have emerged as
critical players in the control of T and B cell function, which has
important implications as potential therapeutic targets in inflam-
mation and immunity. Importantly due to their role also in cancer,
they can also be considered critical players in the ability of the
tumor cell to grow and proliferate but also as key players in the
tumor microenvironment whereby they can be central in orches-
tration signals controlling the impact that inflammation has in
tumor progression and initiation. Future studies using the animal
models described here will be instrumental in addressing these
important questions.
ACKNOWLEDGMENTS
This work was funded by grants SAF2011-27330 and INDISNET
01592006 from the Spanish Ministry of Economy and Competi-
tiveness, and Comunidad de Madrid, respectively, to Pilar Martín,
and R01AI072581 from the National Institutes of Health to Jorge
Moscat.
REFERENCES
Akimoto, K., Mizuno, K., Osada, S.,
Hirai, S., Tanuma, S., Suzuki, K.,
and Ohno, S. (1994). A new mem-
ber of the third class in the pro-
tein kinase C family, PKC lambda,
expressed dominantly in an undif-
ferentiated mouse embryonal carci-
noma cell line and also in many tis-
sues and cells. J. Biol. Chem. 269,
12677–12683.
Barradas, M., Monjas, A., Diaz-Meco,
M. T., Serrano, M., and Moscat, J.
(1999). The downregulation of the
pro-apoptotic protein Par-4 is crit-
ical for Ras-induced survival and
tumor progression. EMBO J. 18,
6362–6369.
Bettelli, E., Oukka, M., and Kuchroo, V.
K. (2007). T(H)-17 cells in the cir-
cle of immunity and autoimmunity.
Nat. Immunol. 8, 345–350.
Chow, C. W., Dong, C., Flavell, R.
A., and Davis, R. J. (2000). c-Jun
NH(2)-terminal kinase inhibits tar-
geting of the protein phosphatase
calcineurin to NFATc1. Mol. Cell.
Biol. 20, 5227–5234.
Crabtree, G. R., and Olson, E. N. (2002).
NFAT signaling: choreographing the
social lives of cells. Cell 109(Suppl.),
S67–S79.
Das, J., Chen, C. H., Yang, L., Cohn,
L., Ray, P., and Ray, A. (2001).
A critical role for NF-kappa B
in GATA3 expression and TH2
differentiation in allergic airway
inflammation. Nat. Immunol. 2,
45–50.
Diaz-Meco, M. T., and Moscat, J.
(2012). The atypical PKCs in
inflammation: NF-kappaB and
beyond. Immunol. Rev. 246,
154–167.
Diaz-Meco, M. T., Municio, M. M.,
Frutos, S., Sanchez, P., Lozano, J.,
Sanz, L., and Moscat, J. (1996).
The product of par-4, a gene
induced during apoptosis, interacts
selectively with the atypical iso-
forms of protein kinase C. Cell 86,
777–786.
Dong, C., Yang, D. D., Wysk, M., Whit-
marsh, A. J., Davis, R. J., and Flavell,
R. A. (1998). Defective T cell dif-
ferentiation in the absence of Jnk1.
Science 282, 2092–2095.
Duran,A., Rodriguez,A., Martin, P., Ser-
rano, M., Flores, J. M., Leitges, M.,
Diaz-Meco, M. T., and Moscat, J.
(2004a). Crosstalk between PKCzeta
and the IL4/Stat6 pathway during T-
cell-mediated hepatitis. EMBO J. 23,
4595–4605.
www.frontiersin.org August 2012 | Volume 3 | Article 241 | 5
Martin and Moscat Atypical PKCs and lymphocytes
Duran, A., Serrano, M., Leitges, M.,
Flores, J. M., Picard, S., Brown,
J. P., Moscat, J., and Diaz-Meco,
M. T. (2004b). The atypical PKC-
interacting protein p62 is an impor-
tant mediator of RANK-activated
osteoclastogenesis. Dev. Cell 6,
303–309.
Gaide, O., Favier, B., Legler, D. F., Bon-
net, D., Brissoni, B., Valitutti, S.,
Bron, C., Tschopp, J., and Thome, M.
(2002). CARMA1 is a critical lipid
raft-associated regulator of TCR-
induced NF-kappa B activation. Nat.
Immunol. 3, 836–843.
Garcia-Cao, I., Lafuente, M. J., Criado,
L. M., Diaz-Meco, M. T., Serrano, M.,
and Moscat, J. (2003). Genetic inac-
tivation of Par4 results in hyperac-
tivation of NF-kappaB and impair-
ment of JNK and p38. EMBO Rep. 4,
307–312.
Gerondakis, S., Grossmann, M., Naka-
mura, Y., Pohl, T., and Grumont,
R. (1999). Genetic approaches in
mice to understand Rel/NF-kappaB
and IkappaB function: transgen-
ics and knockouts. Oncogene 18,
6888–6895.
Grossmann, M., O’Reilly, L. A.,
Gugasyan, R., Strasser, A., Adams,
J. M., and Gerondakis, S. (2000).
The anti-apoptotic activities of Rel
and RelA required during B-cell
maturation involve the regulation
of Bcl-2 expression. EMBO J. 19,
6351–6360.
Gruber, T., Hermann-Kleiter, N.,
Pfeifhofer-Obermair, C., Lutz-
Nicoladoni, C., Thuille, N., Letschka,
T., Barsig, J., Baudler, M., Li, J., Met-
zler, B., Nüsslein-Hildesheim, B.,
Wagner, J., Leitges, M., and Baier, G.
(2009). PKC theta cooperates with
PKC alpha in alloimmune responses
of T cells in vivo. Mol. Immunol. 46,
2071–2079.
Gugasyan, R., Grumont, R., Gross-
mann, M., Nakamura, Y., Pohl, T.,
Nesic, D., and Gerondakis, S. (2000).
Rel/NF-kappaB transcription fac-
tors: key mediators of B-cell activa-
tion. Immunol. Rev. 176, 134–140.
Hardy, R. R., and Hayakawa, K. (2001).
B cell development pathways. Annu.
Rev. Immunol. 19, 595–621.
Harrington, L. E., Hatton, R. D., Man-
gan, P. R., Turner, H., Murphy, T.
L., Murphy, K. M., and Weaver, C.
T. (2005). Interleukin 17-producing
CD4+ effector T cells develop via a
lineage distinct from the T helper
type 1 and 2 lineages. Nat. Immunol.
6, 1123–1132.
Harwood, N. E., and Batista, F. D.
(2010). Early events in B cell acti-
vation. Annu. Rev. Immunol. 28,
185–210.
Hayden, M. S., West, A. P., and
Ghosh, S. (2006). NF-kappaB and
the immune response. Oncogene 25,
6758–6780.
Ito, T., Matsui, Y., Ago, T., Ota, K.,
and Sumimoto, H. (2001). Novel
modular domain PB1 recognizes PC
motif to mediate functional protein–
protein interactions. EMBO J. 20,
3938–3946.
Jaruga, B., Hong, F., Sun, R., Radaeva,
S., and Gao, B. (2003). Crucial role
of IL-4/STAT6 in T cell-mediated
hepatitis: up-regulating eotaxins and
IL-5 and recruiting leukocytes. J.
Immunol. 171, 3233–3244.
Karin, M., and Greten, F. R. (2005). NF-
kappaB: linking inflammation and
immunity to cancer development
and progression. Nat. Rev. Immunol.
5, 749–759.
Lafuente, M. J., Martin, P., Garcia-Cao,
I., Diaz-Meco, M. T., Serrano, M.,
and Moscat, J. (2003). Regulation of
mature T lymphocyte proliferation
and differentiation by Par-4. EMBO
J. 22, 4689–4698.
Lallena, M. J., Diaz-Meco, M. T., Bren,
G., Paya, C. V., and Moscat, J. (1999).
Activation of IkappaB kinase beta by
protein kinase C isoforms. Mol. Cell.
Biol. 19, 2180–2188.
Leitges, M., Sanz, L., Martin, P., Duran,
A., Braun, U., Garcia, J. F., Cama-
cho, F., Diaz-Meco, M. T., Rennert,
P. D., and Moscat, J. (2001). Tar-
geted disruption of the zetaPKC gene
results in the impairment of the
NF-kappaB pathway. Mol. Cell 8,
771–780.
Leitges,M.,Schmedt,C.,Guinamard,R.,
Davoust, J., Schaal, S., Stabel, S., and
Tarakhovsky, A. (1996). Immunod-
eficiency in protein kinase cbeta-
deficient mice. Science 273, 788–791.
Liu, Y., Witte, S., Liu, Y. C., Doyle,
M., Elly, C., and Altman, A. (2000).
Regulation of protein kinase Ctheta
function during T cell activation
by Lck-mediated tyrosine phos-
phorylation. J. Biol. Chem. 275,
3603–3609.
Marsland, B. J., and Kopf, M. (2008).
T-cell fate and function: PKC-theta
and beyond. Trends Immunol. 29,
179–185.
Martin, P., Diaz-Meco, M. T., and
Moscat, J. (2006). The signaling
adapter p62 is an important medi-
ator of T helper 2 cell function
and allergic airway inflammation.
EMBO J. 25, 3524–3533.
Martin, P., Duran, A., Minguet, S., Gas-
par, M. L., Diaz-Meco, M. T., Ren-
nert, P., Leitges, M., and Moscat, J.
(2002). Role of zeta PKC in B-cell
signaling and function. EMBO J. 21,
4049–4057.
Martin, P., Villares, R., Rodriguez-
Mascarenhas, S., Zaballos, A., Leit-
ges, M., Kovac, J., Sizing, I., Ren-
nert, P., Marquez, G., Martinez, A.
C., Diaz-Meco, M. T., and Moscat,
J. (2005). Control of T helper 2 cell
function and allergic airway inflam-
mation by PKCzeta. Proc. Natl. Acad.
Sci. U.S.A. 102, 9866–9871.
Mecklenbrauker, I., Saijo, K., Zheng, N.
Y., Leitges, M., and Tarakhovsky, A.
(2002). Protein kinase Cdelta con-
trols self-antigen-induced B-cell tol-
erance. Nature 416, 860–865.
Miyamoto, A., Nakayama, K., Imaki,
H., Hirose, S., Jiang, Y., Abe, M.,
Tsukiyama, T., Nagahama, H., Ohno,
S., Hatakeyama, S., and Nakayama,
K. I. (2002). Increased proliferation
of B cells and auto-immunity in
mice lacking protein kinase Cdelta.
Nature 416, 865–869.
Moscat, J., and Diaz-Meco, M. T.
(2000). The atypical protein kinase
Cs. Functional specificity mediated
by specific protein adapters. EMBO
Rep. 1, 399–403.
Moscat, J., Diaz-Meco, M. T., and Ren-
nert, P. (2003). NF-kappaB activa-
tion by protein kinase C isoforms
and B-cell function. EMBO Rep. 4,
31–36.
Nakayamada, S., Takahashi, H., Kanno,
Y., and O’Shea, J. J. (2012). Helper
T cell diversity and plasticity. Curr.
Opin. Immunol. 24, 297–302.
Saijo, K., Schmedt, C., Su, I. H., Kara-
suyama, H., Lowell, C. A., Reth, M.,
Adachi, T., Patke, A., Santana, A.,
and Tarakhovsky, A. (2003). Essen-
tial role of Src-family protein tyro-
sine kinases in NF-kappaB activa-
tion during B cell development. Nat.
Immunol. 4, 274–279.
Schulze-Luehrmann, J., and Ghosh, S.
(2006). Antigen-receptor signaling
to nuclear factor kappa B. Immunity
25, 701–715.
Selbie, L. A., Schmitz-Peiffer, C., Sheng,
Y., and Biden, T. J. (1993). Molec-
ular cloning and characterization of
PKC iota, an atypical isoform of pro-
tein kinase C derived from insulin-
secreting cells. J. Biol. Chem. 268,
24296–24302.
Sells, S. F., Wood, D. P. Jr., Joshi-
Barve, S. S., Muthukumar, S., Jacob,
R. J., Crist, S. A., Humphreys,
S., and Rangnekar, V. M. (1994).
Commonality of the gene pro-
grams induced by effectors of apop-
tosis in androgen-dependent and
-independent prostate cells. Cell
Growth Differ. 5, 457–466.
Soloff, R. S., Katayama, C., Lin, M.
Y., Feramisco, J. R., and Hedrick,
S. M. (2004). Targeted deletion of
protein kinase C lambda reveals a
distribution of functions between
the two atypical protein kinase
C isoforms. J. Immunol. 173,
3250–3260.
Sun, Z., Arendt, C. W., Ellmeier, W.,
Schaeffer, E. M., Sunshine, M. J.,
Gandhi, L., Annes, J., Petrzilka, D.,
Kupfer, A., Schwartzberg, P. L., and
Littman, D. R. (2000). PKC-theta
is required for TCR-induced NF-
kappaB activation in mature but not
immature T lymphocytes. Nature
404, 402–407.
Tan, S. L., and Parker, P. J. (2003).
Emerging and diverse roles of pro-
tein kinase C in immune cell sig-
nalling. Biochem. J. 376, 545–552.
Wechsler, R. J., and Monroe, J.
G. (1995). Immature B lympho-
cytes are deficient in expression
of the src-family kinases p59fyn
and p55fgr1. J. Immunol. 154,
1919–1929.
Wooten, M. W., Geetha, T., Seiben-
hener, M. L., Babu, J. R., Diaz-Meco,
M. T., and Moscat, J. (2005). The
p62 scaffold regulates nerve growth
factor-induced NF-kappaB activa-
tion by influencing TRAF6 polyu-
biquitination. J. Biol. Chem. 280,
35625–35629.
Yang, J. Q., Leitges, M., Duran, A., Diaz-
Meco, M. T., and Moscat, J. (2009).
Loss of PKC lambda/iota impairs
Th2 establishment and allergic air-
way inflammation in vivo. Proc. Natl.
Acad. Sci. U.S.A. 106, 1099–1104.
Zhu, J., Yamane, H., and Paul, W. E.
(2010). Differentiation of effector
CD4 T cell populations (∗). Annu.
Rev. Immunol. 28, 445–489.
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 09 May 2012; accepted: 17 July
2012; published online: 06 August 2012.
Citation: Martin P and Moscat J (2012)
Th1/Th2 differentiation and B cell func-
tion by the atypical PKCs and their
regulators. Front. Immun. 3:241. doi:
10.3389/fimmu.2012.00241
This article was submitted to Frontiers in
T Cell Biology, a specialty of Frontiers in
Immunology.
Copyright © 2012 Martin and Moscat .
This is an open-access article distributed
under the terms of the Creative Com-
mons Attribution License, which per-
mits use, distribution and reproduction
in other forums, provided the original
authors and source are credited and sub-
ject to any copyright notices concerning
any third-party graphics etc.
Frontiers in Immunology | T Cell Biology August 2012 | Volume 3 | Article 241 | 6
